Interferon gamma-1b

TERMINATED · PHASE3 · Ovarian Carcinoma, Peritoneal Carcinoma

futility

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.